Cargando…

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD

PURPOSE: Few studies have reported the association between the radiographic characteristics and the development of pneumonia in patients with chronic obstructive pulmonary disease (COPD) treated with inhaled corticosteroids (ICSs). Our study aimed to assess the effect of radiographic phenotypes on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyo Jin, Jin, Kwang Nam, Lee, Hyun Woo, Lee, Jung-Kyu, Park, Tae Yeon, Heo, Eun Young, Kim, Deog Kyeom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503700/ https://www.ncbi.nlm.nih.gov/pubmed/36159655 http://dx.doi.org/10.2147/COPD.S372735

Ejemplares similares

Association between successful weaning from nasogastric tube feeding and thoracic muscle mass in patients with aspiration pneumonia
por: Lee, Hyun Woo, et al.
Publicado: (2023)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Different treatment response to systemic corticosteroids according to white blood cell counts in severe COVID-19 patients
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Prediction of Anthracofibrosis Based on Clinico-Radiographic Findings
por: Park, Tae Yun, et al.
Publicado: (2017)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Clinical implication and risk factor of pneumonia development in mild coronavirus disease 2019 patients
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease
por: Lee, Hyo Jin, et al.
Publicado: (2023)

Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity
por: Lee, Hyun, et al.
Publicado: (2017)

Association between oxygen saturation level during bronchoscopy and post-bronchoscopy adverse events: a retrospective cohort study
por: Kim, So Yeon, et al.
Publicado: (2022)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence
por: Park, Ju-Hee, et al.
Publicado: (2019)

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
por: Morjaria, Jaymin B., et al.
Publicado: (2017)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus: Two Nested Case-Control Studies
por: Lee, Chang-Hoon, et al.
Publicado: (2016)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

A Genome-Wide Association Study in Early COPD: Identification of One Major Susceptibility Loci
por: Lee, Ye-Jin, et al.
Publicado: (2020)

Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
por: Shin, Jiyoung, et al.
Publicado: (2020)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

The Incidence of Brain-Dead Donors Based on Screening and Management Led by Intensivists
por: Lee, Hyo Jin, et al.
Publicado: (2023)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

The regional association between bronchiectasis and lung cancer in chest CT
por: Kim, Yeon Wook, et al.
Publicado: (2016)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD
por: Wu, Ming-Fang, et al.
Publicado: (2016)

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
por: Ridolo, Erminia, et al.
Publicado: (2018)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
por: Yamauchi, Yasuhiro, et al.
Publicado: (2016)

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
por: Wang, Cheng-Yi, et al.
Publicado: (2016)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis
por: Hwang, Hyeontaek, et al.
Publicado: (2023)

Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study
por: Lee, Ji-Ho, et al.
Publicado: (2020)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease
por: Kim, Yeon Wook, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4arg6fmosfl2tc1n34vb9a1260